4 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow AZD0914: new trials by email Literature Review of AZD0914 trials Research Report on AZD0914
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Thorough QT/QTC (TQT) Clinical Trial to Evaluate the Effect of Zoliflodacin on Cardiac Repolarization in Healthy Male and Female Subjects AZD0914, Moxifloxacin, Placebo - Electrocardiogram Repolarisation Abnormality, Gonococcal Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 72 | 2018-09-25 | 2020-03-27 |
| A Study to Evaluate the Safety, Tolerability and Plasma PK of a Single Oral Dose of Zoliflodacin in Healthy Male and Female Volunteers AZD0914 - Gonorrhoea | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 8 | 2018-02-02 | 2019-03-18 |
| AZD0914 Phase 1 ADME Study in Healthy Volunteers AZD0914 - Healthy | Phase 1 | Completed | Entasis Therapeutics | 6 | 2015-01-01 | 2015-06-03 |
| Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea AZD0914, Ceftriaxone - Gonorrhoea | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 180 | 2014-11-25 | 2017-03-22 |
Gonorrhea (3) · Sexually Transmitted Diseases (1)
National Institute of Allergy and Infectious Diseases (NIAID) (3) · Entasis Therapeutics (1)
United States (4)
Irene Mirkin, MD (1)